TEAM 1 (J. BUSSEROLLES)

The team included 38 permanent members of which 24 full professors or associate professors, 1 full INSERM researcher, 13 supporting personnels and between 7 to 12 PhD students and post-docs. The main focus of the team is the improvement of the pharmacology of chronic pain. Pain is a true clinical problem occurring in many patients and in several medical specialties. Pain can differ according to the organ (somatic or visceral) and its pathophysiology (nociceptive, neurogenic and dysfunctional). Nociceptive pain, found in numerous situations, can be reduced by current pharmacological agents such as paracetamol or opioids. For several other pain syndromes, mostly chronic, it is a real challenge to help these patients and to reduce their direct and indirect cost. Indeed, the efficacy of current analgesic drugs used in these pathologies is limited (e.g. for neuropathic pain). Moreover, their benefit/risk ratio is relatively poor with a limited efficacy and/or a high incidence of adverse effects. Thus, innovation in the pain pharmacopeia is absolutely necessary.

We think that this innovation can arise from two research strategies: first by starting researches from the patient in a reverse translational manner, second by deciphering the mechanisms involved in chronic painful conditions to select relevant targets using experimental models as clinically relevant as possible. Three main research axes were developed by our team: Chronic pain in patients: toward a better characterization: Innovation in chronic pain pharmacology, Microbiota-related treatments in chronic abdominal pain.

This work benefits from a strong interaction between clinicians and basic researchers with a strong desire of valorization through several partnerships with academic and private entities. Different clinical pharmacologists are involved in the team from the Clinical Investigation Center (CIC), the CETD (Centre d’Etude et de Traitement de la Douleur) specialized in pain research, or the gastroenterology department of the University hospital, for visceral chronic pain (irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD)). We also developed frequent contacts with other clinicians in Clermont-Ferrand or elsewhere.

Team leader

Jérôme BUSSEROLLES, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
+33(0)4-7317-8235

Members

Youssef AISSOUNI, Senior Engineer, TEAM 1 (J. BUSSEROLLES)
youssef.aissouni@-Code to remove to avoid SPAM-inserm.fr, +33(0)4-7317-8231
Denis ARDID, Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 microbiota axis
denis.ardid@-Code to remove to avoid SPAM-uca.fr, +33 4 73 17 82 39
Nicolas AUTHIER, Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 patient axis
David BALAYSSAC, Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 patient axis
david.balayssac@-Code to remove to avoid SPAM-uca.fr
Julie BARBIER, Assistant Engineer, TEAM 1 (J. BUSSEROLLES)
Mélina BEGOU, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
Célian BERTIN, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 patient axis
celian.bertin@-Code to remove to avoid SPAM-uca.fr
Frédéric CARVALHO, Research Scientist, TEAM 1 (J. BUSSEROLLES), TEAM 1 microbiota axis
frederic.carvalho@-Code to remove to avoid SPAM-uca.fr
Christine CERCY, Technician, TEAM 1 (J. BUSSEROLLES)
christine.cercy@-Code to remove to avoid SPAM-uca.fr
Anaïs CHAMBON, Doctoral Student, TEAM 1 (J. BUSSEROLLES), TEAM 1 microbiota axis
Anais.CHAMBON@-Code to remove to avoid SPAM-uca.fr
Eric CHAPUY, Technician, TEAM 1 (J. BUSSEROLLES)
eric.chapuy@-Code to remove to avoid SPAM-uca.fr
Chouki CHENAF, Medical doctor, TEAM 1 (J. BUSSEROLLES), TEAM 1 patient axis
chouki.chenaf@-Code to remove to avoid SPAM-uca.fr
David CIA, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
david.cia@-Code to remove to avoid SPAM-uca.fr
Emilie CLEMENCON, Administrative Assistant, TEAM 1 (J. BUSSEROLLES)
emilie.clemencon@-Code to remove to avoid SPAM-uca.fr, +33 4 73 17 82 30
Aurore COLLIN, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
aurore.collin@-Code to remove to avoid SPAM-uca.fr
Christine COURTEIX, Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
christine.courteix@-Code to remove to avoid SPAM-uca.fr
Valentine DAUGEY, Doctoral Student, TEAM 1 (J. BUSSEROLLES), TEAM 1 microbiota axis
valentine.daugey@-Code to remove to avoid SPAM-uca.fr
Laurence DAULHAC-TERRAIL, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
Lauriane DELAY, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
lauriane.delay@-Code to remove to avoid SPAM-uca.fr
Agathe GELOT, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 microbiota axis
agathe.gelot@-Code to remove to avoid SPAM-uca.fr
Fabrice Giraudet, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
fabrice.giraudet@-Code to remove to avoid SPAM-uca.fr
Nathalie JACQUEMOT, Assistant Engineer, TEAM 1 (J. BUSSEROLLES)
nathalie.jacquemot@-Code to remove to avoid SPAM-uca.fr
Baptiste JOUFFRE, Doctoral Student, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
baptiste.jouffre@-Code to remove to avoid SPAM-uca.fr
Nicolas KERCKHOVE, Clinical project manager, TEAM 1 (J. BUSSEROLLES), TEAM 1 patient axis
nicolas.kerckhove@-Code to remove to avoid SPAM-uca.fr
Stéphane LOLIGNIER, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
+33(0)4-7317-8235
Christophe MALLET, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
christophe.mallet@-Code to remove to avoid SPAM-uca.fr
Fabien MARCHAND, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
fabien.marchand@-Code to remove to avoid SPAM-uca.fr, +33(0)4-7317-8231
Mathieu MELEINE, Senior Engineer, TEAM 1 (J. BUSSEROLLES)
mathieu.meleine@-Code to remove to avoid SPAM-uca.fr
Mireille MONTBEL, Technician, TEAM 1 (J. BUSSEROLLES)
mireille.montbel@-Code to remove to avoid SPAM-uca.fr
Gisèle PICKERING, Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 patient axis
gisele.pickering@-Code to remove to avoid SPAM-uca.fr
Laetitia PRIVAL, Assistant Engineer, TEAM 1 (J. BUSSEROLLES)
laetitia.prival@-Code to remove to avoid SPAM-uca.fr
Patrice QUINTANA, Postdoctoral Researcher, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
Damien RICHARD, Medical doctor, TEAM 1 (J. BUSSEROLLES), TEAM 1 patient axis
damien.richard@-Code to remove to avoid SPAM-uca.fr
Laurent SAKKA, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
Julien SCANZI, Medical doctor, TEAM 1 (J. BUSSEROLLES), TEAM 1 microbiota axis
Eric WERSINGER, Assistant Professor, TEAM 1 (J. BUSSEROLLES), TEAM 1 - Innovation axis
eric.wersinger@-Code to remove to avoid SPAM-uca.fr

Journal articles

2024

ref_biblio: Maëva Meynier, Valentine Daugey, Geoffroy Mallaret, Sandie Gervason, Mathieu Meleine, et al.. Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice. Gut microbes, 2024, 16 (1), pp.2298026. ⟨10.1080/19490976.2023.2298026⟩. ⟨hal-04371864⟩
Accès au texte intégral et bibtex

2023

ref_biblio: Karim Atmani, Mathieu Meleine, Ludovic Langlois, Moïse Coëffier, Pablo Brumovsky, et al.. Involvement of acid sensing ion channel (ASIC)-3 in an acute urinary bladder-colon cross sensitization model in rodent. Frontiers in Pain Research, 2023, 4, ⟨10.3389/fpain.2023.1083514⟩. ⟨hal-04326627⟩
Accès au bibtex

ref_biblio: David Balayssac, Jérôme Busserolles, Catherine Broto, Cristelle Dalbos, Laetitia Prival, et al.. Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project. Biomedicine and Pharmacotherapy, 2023, 167, pp.115535. ⟨10.1016/j.biopha.2023.115535⟩. ⟨hal-04213471⟩
Accès au texte intégral et bibtex

ref_biblio: David Balayssac, Julie Durif, Céline Lambert, Cristelle Dalbos, Eric Chapuy, et al.. Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine. Toxics, 2023, 11 (12), pp.1004. ⟨10.3390/toxics11121004⟩. ⟨hal-04332718⟩
Accès au texte intégral et bibtex

ref_biblio: David Balayssac, Bruno Pereira, Juliette Desmard, Hugo Viers, Carole Barillon, et al.. Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study. European Journal of Cancer Care, 2023, 2023, pp.1 - 9. ⟨10.1155/2023/7746349⟩. ⟨hal-04213488⟩
Accès au texte intégral et bibtex

ref_biblio: Célia Chamignon, Geoffroy Mallaret, Julie Riviere, Marthe Vilotte, Sead Chadi, et al.. Beneficial Effects of Lactobacilli Species on Intestinal Homeostasis in Low-Grade Inflammation and Stress Rodent Models and Their Implication in the Modulation of the Adhesive Junctional Complex. Biomolecules, 2023, 13 (9), pp.1295. ⟨10.3390/biom13091295⟩. ⟨hal-04538013⟩
Accès au texte intégral et bibtex

ref_biblio: Sandie Gervason, Mathieu Meleine, Stéphane Lolignier, Maëva Meynier, Valentine Daugey, et al.. Antihyperalgesic properties of gut microbiota: Parabacteroides distasonis as a new probiotic strategy to alleviate chronic abdominal pain. Pain, 2023, ⟨10.1097/j.pain.0000000000003075⟩. ⟨hal-04316524⟩
Accès au bibtex

ref_biblio: Angeline Ginzac, Emilie Thivat, Caroline Petorin, Damien Richard, Pauline Herviou, et al.. A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?. Cancer Chemotherapy and Pharmacology, 2023, ⟨10.1007/s00280-023-04603-x⟩. ⟨hal-04297253⟩
Accès au texte intégral et bibtex

ref_biblio: Joanes Grandjean, Gabriel Desrosiers-Gregoire, Cynthia Anckaerts, Diego Angeles-Valdez, Fadi Ayad, et al.. A consensus protocol for functional connectivity analysis in the rat brain. Nature Neuroscience, 2023, 26 (4), pp.673-681. ⟨10.1038/s41593-023-01286-8⟩. ⟨hal-04268925⟩
Accès au texte intégral et bibtex

ref_biblio: Baptiste Jouffre, Alexandre Acramel, Mathilde Belnou, Maria Francesca Santolla, Marianna Talia, et al.. Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action. Scientific Reports, 2023, 13 (1), pp.1326. ⟨10.1038/s41598-023-28062-9⟩. ⟨hal-04087799⟩
Accès au texte intégral et bibtex

ref_biblio: Baptiste Jouffre, Alexandre Acramel, Yves Jacquot, Laurence Daulhac, Christophe Mallet. GPER involvement in inflammatory pain. Steroids, 2023, 200, pp.109311. ⟨10.1016/j.steroids.2023.109311⟩. ⟨hal-04337675⟩
Accès au bibtex

ref_biblio: Alexandra Jurczak, Katalin Sandor, Alex Bersellini Farinotti, Emerson Krock, Matthew Hunt, et al.. Insights into FcγR involvement in pain-like behavior induced by an RA-derived anti-modified protein autoantibody. Brain, Behavior, and Immunity, 2023, 113, pp.212-227. ⟨10.1016/j.bbi.2023.07.001⟩. ⟨hal-04327564⟩
Accès au bibtex

ref_biblio: Spiro Khoury, Jenny Colas, Véronique Breuil, Eva Kosek, Aisha Ahmed, et al.. Identification of Lipid Biomarkers for Chronic Joint Pain Associated with Different Joint Diseases. Biomolecules, 2023, 13 (2), pp.342. ⟨10.3390/biom13020342⟩. ⟨hal-04010965⟩
Accès au texte intégral et bibtex

ref_biblio: Thibault Léger, Aurélien Brun, Kassandra Lanchais, Jean-Paul Rigaudière, Arnaud Briat, et al.. Docosahexaenoic acid and etanercept could reduce functional and metabolic alterations during collagen-induced arthritis in rats without any synergistic effect. Life Sciences, 2023, 327, pp.121826. ⟨10.1016/j.lfs.2023.121826⟩. ⟨hal-04162926⟩
Accès au bibtex

ref_biblio: Flore Maillard, Maëva Meynier, Stanislas Mondot, Frederic Pepke, Chloé Galbert, et al.. From In Vitro to In Vivo: A Rational Flowchart for the Selection and Characterization of Candidate Probiotic Strains in Intestinal Disorders. Microorganisms, 2023, 11 (4), pp.906. ⟨10.3390/microorganisms11040906⟩. ⟨hal-04057783⟩
Accès au texte intégral et bibtex

ref_biblio: Christophe Mallet, Jules Desmeules, Rassa Pegahi, Alain Eschalier. An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact. Journal of Pain Research, 2023, 16, pp.1081 - 1094. ⟨10.2147/jpr.s393809⟩. ⟨hal-04337681⟩
Accès au texte intégral et bibtex

ref_biblio: Julie Maraud, Sabrina Bedhomme, Bruno Pereira, Sophie Trévis, Marine Jary, et al.. Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study. Cancers, 2023, 15 (12), pp.3190. ⟨10.3390/cancers15123190⟩. ⟨hal-04213499⟩
Accès au texte intégral et bibtex

ref_biblio: Nazarine Mokhtar, Marcin Drop, Florian Jacquot, Sylvain Lamoine, Eric Chapuy, et al.. The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats. Biomolecules, 2023, Recent Advances on 5-HT6 Receptors, 13 (2), pp.364. ⟨10.3390/biom13020364⟩. ⟨hal-04094286⟩
Accès au texte intégral et bibtex

ref_biblio: Nazarine Mokhtar, Stephane Doly, Christine Courteix. Diabetic Neuropathic Pain and Serotonin: What Is New in the Last 15 Years?. Biomedicines, 2023, Pathological Mechanisms in Diabetes 2.0, 11 (7), pp.1924. ⟨10.3390/biomedicines11071924⟩. ⟨hal-04323925⟩
Accès au texte intégral et bibtex

ref_biblio: Edouard Montigné, David Balayssac. Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies. Pharmaceuticals, 2023, 16 (10), pp.1363. ⟨10.3390/ph16101363⟩. ⟨hal-04285363⟩
Accès au texte intégral et bibtex

ref_biblio: Elodie Picard, Nicolas Kerckhove, Amaury François, Ludivine Boudieu, Elisabeth Billard, et al.. Role of T CD4+ cells, macrophages, C-low threshold mechanoreceptors and spinal Cav3.2 channels in inflammation and related pain-like symptoms in murine inflammatory models. British Journal of Pharmacology, 2023, 180 (4), pp.385-400. ⟨10.1111/bph.15956⟩. ⟨hal-03790651⟩
Accès au bibtex

2022

ref_biblio: Karim Atmani, Fabien Wuestenberghs, Maximilien Baron, Illona Bouleté, Charlène Guérin, et al.. Bladder-colon chronic cross-sensitization involves neuro-glial pathways in male mice. World Journal of Gastroenterology, 2022, 28 (48), pp.6935-6949. ⟨10.3748/wjg.v28.i48.6935⟩. ⟨hal-04326781⟩
Accès au bibtex

ref_biblio: Celian Bertin, Julien Bezin, Chouki Chenaf, Jessica Delorme, Nicolas Kerckhove, et al.. Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use. Frontiers in Psychiatry, 2022, 13, ⟨10.3389/fpsyt.2022.893590⟩. ⟨hal-03815296⟩
Accès au texte intégral et bibtex

ref_biblio: Noémie Delage, Nathalie Cantagrel, Jessica Delorme, Bruno Pereira, Christian Dualé, et al.. Transcultural validation of a French–European version of the Prescription Opioid Misuse Index Scale (POMI-5F). Canadian Journal of Anesthesia / Journal canadien d'anesthésie, 2022, 69 (8), pp.1042-1052. ⟨10.1007/s12630-022-02210-7⟩. ⟨hal-04256540⟩
Accès au bibtex

ref_biblio: K. Delanoe, F. Marchand, E. Lingueglia, Emmanuel Deval. Canaux ASIC senseurs de l’acidification, lysophosphatidylcholine et douleur chronique. Douleur et Analgésie, 2022, 35 (4), pp.231-238. ⟨10.3166/dea-2022-0238⟩. ⟨hal-04011485⟩
Accès au bibtex

ref_biblio: Lauriane Delay, Julie Barbier, Youssef Aissouni, Alexandra Jurczak, Ludivine Boudieu, et al.. Tyrosine kinase type A–specific signalling pathways are critical for mechanical allodynia development and bone alterations in a mouse model of rheumatoid arthritis. Pain, 2022, 163 (7), pp.e837-e849. ⟨10.1097/j.pain.0000000000002492⟩. ⟨hal-04316536⟩
Accès au bibtex

ref_biblio: Amélie Démosthènes, Benoît Sion, Fabrice Giraudet, Xavier Moisset, Laurence Daulhac, et al.. In-Depth Characterization of Somatic and Orofacial Sensitive Dysfunctions and Interfering-Symptoms in a Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mouse Model. Frontiers in Neurology, 2022, 12, pp.789432. ⟨10.3389/fneur.2021.789432⟩. ⟨hal-03552469⟩
Accès au texte intégral et bibtex

ref_biblio: Sophie L Fayad, Guillaume Ourties, Benjamin Le Gac, Baptiste Jouffre, Sylvain Lamoine, et al.. Centrally expressed Cav3.2 T-type calcium channel is critical for the initiation and maintenance of neuropathic pain. eLife, 2022, 11, pp.e79018. ⟨10.7554/elife.79018⟩. ⟨hal-03942925⟩
Accès au texte intégral et bibtex

ref_biblio: Sophie Fayad, Guillaume Ourties, Benjamin Le Gac, Baptiste Jouffre, Sylvain Lamoine, et al.. Centrally expressed Cav3.2 T-type calcium channel is critical for the initiation and maintenance of neuropathic pain. eLife, 2022, 11, ⟨10.7554/eLife.79018⟩. ⟨hal-04256569⟩
Accès au bibtex

ref_biblio: Fabrice Giraudet, Marie Selvy, Nicolas Kerckhove, Bruno Pereira, Fantine Barreau, et al.. Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study. European Archives of Oto-Rhino-Laryngology, 2022, 279 (4), pp.2197-2201. ⟨10.1007/s00405-021-07234-1⟩. ⟨hal-03813006⟩
Accès au bibtex

ref_biblio: Cyril Goudet, Fabien Marchand. Editorial: Molecular mechanisms of nociception. Frontiers in Molecular Neuroscience, 2022, 15, pp.1025230. ⟨10.3389/fnmol.2022.1025230⟩. ⟨hal-03805607⟩
Accès au texte intégral et bibtex

ref_biblio: Florian Jacquot, Spiro Khoury, Bonnie Labrum, Kévin Delanoe, Ludivine Pidoux, et al.. Lysophosphatidylcholine 16:0 mediates chronic joint pain associated to rheumatic diseases through acid-sensing ion channel 3. Pain, 2022, 163 (10), pp.1999-2013. ⟨10.1097/j.pain.0000000000002596⟩. ⟨hal-03855419⟩
Accès au texte intégral et bibtex

ref_biblio: Alexandra Jurczak, Lauriane Delay, Julie Barbier, Nils Simon, Emerson Krock, et al.. Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3–dependent sensitization. Pain, 2022, 163 (8), pp.1542-1559. ⟨10.1097/j.pain.0000000000002543⟩. ⟨hal-04061760⟩
Accès au texte intégral et bibtex

ref_biblio: Nicolas Kerckhove, Noémie Delage, Célian Bertin, Emmanuelle Kuhn, Nathalie Cantagrel, et al.. Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale. Frontiers in Pharmacology, 2022, 13, ⟨10.3389/fphar.2022.947006⟩. ⟨hal-04256522⟩
Accès au bibtex

ref_biblio: Nicolas Kerckhove, Noémie Delage, Sébastien Cambier, Nathalie Cantagrel, Eric Serra, et al.. eDOL mHealth App and Web Platform for Self-monitoring and Medical Follow-up of Patients With Chronic Pain: Observational Feasibility Study. JMIR Formative Research, 2022, 6 (3), pp.e30052. ⟨10.2196/30052⟩. ⟨hal-04256443⟩
Accès au bibtex

ref_biblio: Nicolas Kerckhove, David Tougeron, Côme Lepage, Denis Pezet, Karine Le Malicot, et al.. Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial. BMC Cancer, 2022, 22 (1), pp.1-11. ⟨10.1186/s12885-022-09806-8⟩. ⟨hal-03770150⟩
Accès au texte intégral et bibtex

ref_biblio: Guy Khalaf, Claudia Mattern, Mélina Begou, Odile Boespflug-Tanguy, Charbel Massaad, et al.. Mutation of Proteolipid Protein 1 Gene: From Severe Hypomyelinating Leukodystrophy to Inherited Spastic Paraplegia. Biomedicines, 2022, 10 (7), pp.1709. ⟨10.3390/biomedicines10071709⟩. ⟨hal-03798606⟩
Accès au texte intégral et bibtex

ref_biblio: Sylvain Lamoine, Mélissa Cumenal, David Barriere, Vanessa Pereira, Mathilde Fereyrolles, et al.. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice. International Journal of Molecular Sciences, 2022, 23 (1), pp.98. ⟨10.3390/ijms23010098⟩. ⟨hal-03703118⟩
Accès au texte intégral et bibtex

ref_biblio: Catherine Laporte, Frédéric Fortin, Julie Dupouy, Aurélie Quirin, Bruno Pereira, et al.. Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care. International Journal of Environmental Research and Public Health, 2022, 19 (22), pp.14845. ⟨10.3390/ijerph192214845⟩. ⟨hal-04184143⟩
Accès au texte intégral et bibtex

ref_biblio: Maha Mabrouk, Mohamed El Ayed, Amélie Démosthènes, Youssef Aissouni, Ezzedine Aouani, et al.. Antioxidant effect of grape seed extract corrects experimental autoimmune encephalomyelitis behavioral dysfunctions, demyelination, and glial activation. Frontiers in Immunology, In press, ⟨10.3389/fimmu.2022.960355⟩. ⟨hal-03768907⟩
Accès au texte intégral et bibtex

ref_biblio: Geoffroy Mallaret, Amandine Lashermes, Mathieu Meleine, Ludivine Boudieu, Julie Barbier, et al.. Involvement of toll-like receptor 5 on mouse model of colonic hypersensitivity induced by neonatal maternal separation. World Journal of Gastroenterology, 2022, 28 (29), pp.3903-3916. ⟨10.3748/wjg.v28.i29.3903⟩. ⟨hal-03987265⟩
Accès au bibtex

ref_biblio: Maëva Meynier, Elodie Baudu, Nathalie Rolhion, Manon Defaye, Marjolène Straube, et al.. AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms. Gut microbes, 2022, 14 (1), pp.1-21. ⟨10.1080/19490976.2021.2022997⟩. ⟨hal-03555153⟩
Accès au texte intégral et bibtex

ref_biblio: Ludivine Pidoux, Kevin Delanoe, Julie Barbier, Fabien Marchand, Eric Lingueglia, et al.. Single Subcutaneous Injection of Lysophosphatidyl-Choline Evokes ASIC3-Dependent Increases of Spinal Dorsal Horn Neuron Activity. Frontiers in Molecular Neuroscience, 2022, 15, pp.880651. ⟨10.3389/fnmol.2022.880651⟩. ⟨hal-03855415⟩
Accès au texte intégral et bibtex

ref_biblio: Céline Preux, Marion Bertin, Andréa Tarot, Nicolas Authier, Nathalie Pinol, et al.. Prevalence of Opioid Use Disorder among Patients with Cancer-Related Pain: A Systematic Review. Journal of Clinical Medicine, 2022, 11 (6), pp.1594. ⟨10.3390/jcm11061594⟩. ⟨hal-03983745⟩
Accès au texte intégral et bibtex

ref_biblio: Vassili Prudhomme, Mélissa Cucca, Lionel Nauton, Elsa Andrieu, Mathilde Fereyrolles, et al.. Design, synthesis and biological evaluation of conformationnally-restricted analogues of E7010 as inhibitors of tubulin assembly (ITA) and vascular disrupting agents (VDA). European Journal of Medicinal Chemistry, 2022, 244, pp.114809. ⟨10.1016/j.ejmech.2022.114809⟩. ⟨hal-03959739⟩
Accès au bibtex

ref_biblio: Annabelle Réaux-Le-Goazigo, Benoît Beliard, Lauriane Delay, Line Rahal, Julien Claron, et al.. Ultrasound localization microscopy and functional ultrasound imaging reveal atypical features of the trigeminal ganglion vasculature. Communications Biology, 2022, ⟨10.1038/s42003-022-03273-4⟩. ⟨hal-03649783⟩
Accès au texte intégral et bibtex

ref_biblio: Benjamin Rolland, Caroline Lions, Vincent Di Beo, Patrizia Carrieri, Nicolas Authier, et al.. Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study). Harm Reduction Journal, 2022, 19 (1), pp.119. ⟨10.1186/s12954-022-00702-9⟩. ⟨inserm-04050246⟩
Accès au texte intégral et bibtex

ref_biblio: Anne-Priscille Trouvin, Chouki Chenaf, Marie Riquelme, Emmanuel Curis, Ioannis Nicolis, et al.. Crise des opioïdes : la pratique rhumatologique augmente-t-elle le risque pour les patients ? Enquête nationale sur la prescription d’opioïdes par les rhumatologues et l’adhésion aux recommandations relatives à l’utilisation des opioïdes forts. Revue du Rhumatisme, 2022, 89 (2), pp.145--152. ⟨10.1016/j.rhum.2021.10.007⟩. ⟨hal-03831134⟩
Accès au bibtex

Book sections

2022

ref_biblio: Christine Cercy, Corinne Gardais, Thibault Cardon. Les stalles du couvent des Dames de l’Abbiette (Lille) : entre vestiges et culture matérielle. Lemé-Hébuterne, Kristiane; Billiet, Frédéric. Les stalles de la cathedrale d'Amiens : 500 ans, Stalles de Picardie, Misericordia International, pp.137-158, 2022. ⟨hal-03876984⟩
Accès au texte intégral et bibtex

Poster communications

2023

ref_biblio: Nazarine Mokhtar, Marcin Drop, Frédéric Lamaty, Paweł Zajdel, Philippe Marin, et al.. Diabetic neuropathic pain improvement by inhibition of constitutive 5-HT 6 receptor activity in rats. Neuropathic Pain Special Interest Group (NeuPSIG) 2023 International Congress on Neuropathic Pain, Sep 2023, Lisbon, Portugal. ⟨hal-04324131⟩
Accès au texte intégral et bibtex

ref_biblio: Armel Soubeiga, Jessem Ettaghouti, Violaine Antoine, Alice Corteval, Nicolas Kerckhove, et al.. Clustering de séries chronologiques de patients souffrant de douleurs chroniques. Extraction et Gestion des Connaissances (EGC) - 2023, Jan 2023, Lyon, France. . ⟨hal-04063254⟩
Accès au texte intégral et bibtex

ref_biblio: Ophélie Uriot, Sylvain Denis, Nicolas Kerckhove, Julien Scanzi, Lucie Etienne-Mesmin, et al.. Development of a new in vitro model of inflammatory bowel syndrome gut microbiome. 10th FEMS Congress of European Microbiologists, Jul 2023, Hambourg (Neversdorf), Germany. ⟨hal-04215089⟩
Accès au bibtex

2022

ref_biblio: R. Auguste, E. Jagu, C. Courteix, S. Ducki. Targeting PDZ-mediated protein-protein interactions against neuropathic pain.. European School of Medicinal Chemistry ESMEC, 41st Advanced Course of Medicinal Chemistry and Seminar for PhD students, Jul 2022, Urbino, Italy. ⟨hal-04069002⟩
Accès au bibtex

ref_biblio: Christine Cercy. L’approche documentaire des couvents de Lille (XIVe-XIXe siècles). Inrap. Études documentaires et études d’archives en archéologie préventive : 6e séminaire scientifique et technique de l’Inrap, Nov 2022, Lyon, France. , 2022, ⟨10.34692/9xd1-2e33⟩. ⟨hal-03927489⟩
Accès au texte intégral et bibtex

ref_biblio: M. Morez, L. Prival, Y. Aissouni, E. Bourinet, O. Roy, et al.. Disrupting HCN channels - TRIP8b interaction is an efficient strategy to decrease acute oxaliplatin-induced peripheral neuropathy symptoms.. IASP 2022 World Congress on pain, Sep 2022, Toronto, Canada. ⟨hal-04068893⟩
Accès au bibtex

Proceedings

2022

ref_biblio: M. Morez, Y. Aissouni, L. Prival, J. Barbier, D. Balayssac, et al.. Modulation of HCN channel activity in oxaliplatin-induced peripheral neuropathy.. Fundamental & Clinical Pharmacology, 36 (S1), pp.10-11, 2022, ⟨10.1111/fcp.12786⟩. ⟨hal-04026980⟩
Accès au bibtex

Reports

2023

ref_biblio: Anne Pereira de Vasconcelos, Valentina Andreeva, Serge Boarini, Anne Bourdieu, Jean-Marie Burkhardt, et al.. Avis de l'Anses relatif aux lignes directrices visant à limiter l’exposition des personnes aux champs électromagnétiques (100 kHz – 300 GHz). Saisine n°2021-SA-0192, Anses. 2023, 50 p. ⟨anses-04241299⟩
Accès au texte intégral et bibtex

2022

ref_biblio: Estelle Delmont, Christine Cercy, Vaiana Vincent. Hauts-de-France, Nord, Saultain, 19 bis Avenue Henri Barbusse. La cense de Saultain, une dépendance de l’abbaye Saint-Jean de Valenciennes.. INRAP. 2022, https://dolia.inrap.fr/flora/ark:/64298/0168138. ⟨hal-04523341⟩
Accès au bibtex

Preprints, Working Papers, ...

2022

ref_biblio: Sophie L Fayad, Guillaume Ourties, Benjamin Le Gac, Baptiste Jouffre, Sylvain Lamoine, et al.. Centrally expressed Cav3.2 T-type calcium channel is critical for the initiation and maintenance of neuropathic pain. 2022. ⟨hal-03746638⟩
Accès au bibtex